Bryan J. McVerry, MD

  • Pulmonary, Allergy and Critical Care Medicine
  • Associate Professor of Medicine
  • Associate Professor of Environmental and Occupational Health
  • Associate Professor of Clinical and Translational Science
  • Associate Chief of Strategy and Development

    Education & Training

  • BS, Lehigh University, 1992
  • MD, Georgetown University, 1997
  • Residency, Internal Medicine, University of Chicago Hospital, 2000
  • Post-Doctoral Research Fellowship, Emergency Medicine, University of Chicago, Pritzker School of Medicine, 2001
  • Post-Doctoral Clinical and Research Fellowship, Pulmonary and Critical Care, Johns Hopkins University School of Medicine, 2005
Alpha Omega Alpha, Georgetown University School Medicine, 1996
Resuscitation Science Research Fellowship, Univ of Chicago Dept of Medicine, 2000-2001
Individual Ruth L. Kirschstein National Research Service Award (F32), 2004-2005
Ironman Triathalon Finisher, 2004 & 2008
NIH Mentored Clinical Scientist Research Career Development Award (K08), 2007-2012
Conferral of Tenure, 2017
Representative Publications

Kitsios GD, Yang L, Manatakis DV, Nouraie SM, Evankovich J, Bain W, Dunlap DD, Shah F, Barbash IJ, Rapport SF, Zhang Y, DeSensi RS, Weathington NM, Chen BB, Ray P, Mallampalli RK, Benos P, Lee JS, Morris A, McVerry BJ. ARDS subphenotypes beyond ARDS: prognostic enrichment in mechanically-ventilated patients with or at risk for ARDS. Crit Care Med. 2019; In Press.

National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med. 2019; 380(21): 1997-2008.

Shah FA, Kitsios GD, Zhang Y, Morris A, Yende S, Huang D, O'Donnell CP, McVerry BJ. Rationale for and Design of the Study of Early Enteral Dextrose in Sepsis: A Pilot Randomized Controlled Trial. JPEN. 2019; doi: 10.1002/jpen.1608: [Epubaheadofprint].

Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP, Bajwa EK, Donahoe MP, McVerry BJ. Allogeneic Mesenchymal Stromal Cells for Treatment of Moderate to Severe ARDS (START): A Randomized Phase 2a Safety Trial. Lancet Respiratory Medicine. 2019; Feb; 7(2): 154-162.

Kitsios GD, Fitch A, Manatakis DV, Rapport SF, Li K, Qin S, Huwe J, Zhang Y, Doi Y, Methé B, Benos P, Morris A, McVerry BJ. Respiratory microbiome profiling as a diagnostic tool for bacterial pneumonia in mechanically ventilated patients. Front Microbiol. 2018; 9:1413: doi:10.3389/fmicb.2018.01413.

Shah FA, Singamsetty S, Guo L, Chuan BW, McDonald S, Cooper BA, O'Donnell BJ, Stefanovski D, Wice B, Zhang Y, O'Donnell CP, McVerry BJ. Stimulation of the Endogenous Incretin Glucose-Dependent Insulinotropic Peptide by Enteral Dextrose Improves Glucose Homeostasis and Inflammation in Murine Endotoxemia. Transl Res. 2018; Mar;193:1-12: doi:10.1016/j.trsl.2017.11.001.

For complete bibliography Click Here.

Research Interests

Dr. McVerry’s research interest is focused on translational investigation of the biological mechanisms underlying the development and consequences of sepsis and acute lung injury. His research efforts are designed to span the continuum from the bench to the bedside. Currently interests include: 1) contributions of the host microbiome to the evolution of and outcomes following critical illness, 2) mechanisms of glucose homeostasis and regulation of host response to nutritional support in critical illness, 3) biological phenotypes of critical illness and the impact on treatment decisions and outcomes, 4) mechanisms underlying the development of cognitive impairment in critically ill patients, and 5) development of novel therapeutic strategies for prevention and treatment of acute respiratory failure in the context of pneumonia and/or sepsis.